Marks Peter Ashleyinsider trades

In SEC Form 4 filings, Marks Peter Ashley is listed as Director of Alterity Therapeutics Ltd (ATHE). In the last 90 days, Marks Peter Ashley bought $23.8K of Alterity Therapeutics Ltd (ATHE) on the open market and sold none. The purchase was $23.8K of Alterity Therapeutics Ltd (ATHE) on Aug 31.

Companies and roles

Company	Role	Transactions	Last filed
ATHEAlterity Therapeutics Ltd	Director	2	Sep 8

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-08

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
ATHEAlterity Therapeutics Ltd	Aug 31	Sep 8	P	47,620	$0.50	Purchase +$23,810	191,340	No	Form 4
ATHEAlterity Therapeutics Ltd	Aug 31	Sep 8	P · derivative	47,620	$0.50	Purchase +$23,810	not reported	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.